Designed RANKL fragment peptides (Partial agonist of RANKL) treat fibrosis.
Blockade of novel target, Netrin-4 Unc5B signaling.
Treatment of allergies and mastocytoma with Mast cell targeting antibodies
A new therapeutic mechanism to inhibit cytokine production from topical IL-17-producing cells by CD96 neutralizing antibodies
Treatment of immunological diseases by a new mechanism to control the immune Th1/Th2 balance
Original method and hepatocyte reproduced hepatobiliary function
A novel technology loosens tight junction of BBB and supports drug transportation into brain.
Selective inhibition of Periostin variant (PN1) by monoclonal antibody
Variant Specific Periostin Neutralization for Diabetic Retinopathy
About Bionauts.jp
